Gardasil to be a $10 billion earner if approved for male patients: analyst
Merck's human papillomavirus vaccine Gardasil could become a blockbuster 10 times over if the vaccine if the drugmaker can win approval for use of the treatment in men.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.